Source-aware monitoring
Track configured authority pages and literature searches with source identity, retrieval context and review status attached.
Early access
Regulatory intelligence · local-first · traceable evidence
Know what changed. Keep what you reviewed.
Kelavon Monitor helps regulatory and pharmacovigilance teams monitor authority websites and screen PubMed literature. Retrieved evidence is versioned and kept locally, while concurrent work is merged explicitly rather than silently overwritten.
Product proof
A focused operating model, not a feature list.
Versioned evidence
Retrieved content versions are retained instead of being overwritten by the next scan or upstream page change.
Human-resolved conflicts
Concurrent local work uses field-level comparison and explicit conflict resolution rather than last-write-wins data loss.
Reviewable history
Actor, device, time and reason remain connected to screening decisions and material record changes.
Commercial engagement
A bounded offer before a broad rollout.
A limited monitoring deployment with named authority sources, searches, screening volume, review ownership and follow-up rules.
Included in the fit discussion
- Named authority-source and PubMed searches
- Versioned evidence capture and screening
- Conflict and follow-up ownership
- Local-first deployment for the agreed team
Outside the default boundary
- A universal regulatory-source guarantee
- Autonomous safety or regulatory decisions
- Sources or integrations outside the written scope
Pilot success evidence
- Agreed searches run reproducibly
- Changed evidence remains versioned
- Review decisions and conflicts are attributable
How the work flows
Monitoring is only useful when the evidence survives the alert.
01
Define sources and searches
Configure the authority pages, website targets and literature queries relevant to the monitored scope.
02
Capture changed evidence
Retrieve and retain new versions with their source and content identity intact.
03
Screen and classify
Record relevance, ownership, reason and follow-up without confusing automated detection with human review.
04
Connect follow-up
Route material findings toward regulatory, safety, signal or commitment work as integration becomes available.
Best fit
Start where the operational pain is specific.
- Regulatory-intelligence and change-assessment teams
- Pharmacovigilance literature-screening teams
- Small and specialist organizations needing local control
- Shared-folder teams that need explicit merge behavior
What exists now
A working local-first design covers website change monitoring, PubMed screening, retained evidence, history and recoverable shared-folder collaboration. Early access verifies source coverage and operating procedures one deployment at a time.
Important limitation
Source availability, page structure and external APIs can change. Monitor detects and preserves candidate evidence; qualified people remain responsible for source coverage, relevance decisions and downstream regulatory or safety action.
Designed to connect
Useful independently. A clear role in the platform later.
Within Kelavon Life Sciences, Monitor is designed to feed reviewed intelligence into Regulatory, Safety, Signals and Commitments without losing the source version that triggered the work.